Sandbox:Sogand: Difference between revisions
Jump to navigation
Jump to search
Line 323: | Line 323: | ||
{{familytree | | | | | | | |,|-|-|-|^|-|-|.| | | | | | | | | | |!| | | | | | | | | |!| | | |}} | {{familytree | | | | | | | |,|-|-|-|^|-|-|.| | | | | | | | | | |!| | | | | | | | | |!| | | |}} | ||
{{familytree | | | | | | | | E01 | | | E02 | | | | | | | | | | E03 | | | | | | | | E04 | | |E01=Evidence of abnormality,comparison of mobility with that of known abnormalities, if HBS suspected: solubility test |E02=Separation/quantification |E03=Evalution of all data and findings |E04=Evalution of all data and findings | | |}} | {{familytree | | | | | | | | E01 | | | E02 | | | | | | | | | | E03 | | | | | | | | E04 | | |E01=Evidence of abnormality,comparison of mobility with that of known abnormalities, if HBS suspected: solubility test |E02=Separation/quantification |E03=Evalution of all data and findings |E04=Evalution of all data and findings | | |}} | ||
{{familytree | | | | | | | | |!| | | | |!| | | | | | | | | | | |!| | | | | | | | | |!| | }} | |||
{{familytree | | | | | | | | |`|-|v|-|-|'| | | | | | | | | | | |!| | | | | | | | | |!| | }} | |||
{{familytree | | | | | | | | | | |!| | | | | | | | | | | | | | F01 | | | | | | | | F02 | | |F01=Diagnisis of β-thalassemia |F02=Dignisis of α-thalassemia | | |}} | |||
{{familytree | | | | | | | | | | |!| | | | | | | | | | | | | | |!| | | | | | | | | | | | |}} | |||
{{familytree | | | | | | | | | | G01 | | | | | | | | | | | | | G02 | | |G01=DNA sequencing if needed |G02=DNA sequencing if needed(thalassemia major, thalassemia intermedia | | |}} | |||
{{familytree | | | | | | | | | | |!| | | }} | |||
{{familytree | | | | | | | | | | H01 | | |H01=Evaluation of all data and findings(including blood count ethnic and origin | | |}} | |||
{{familytree | | | | | | | | | | |!| | | | }} | |||
{{familytree | | | | | | | | | | I01 | | |I01=Diagnosis of hemoglobinopathy | | |}} | |||
== References == | == References == |
Revision as of 17:54, 7 September 2018
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Differentiating [disease name] from other diseases on the basis of [symptom 1], [symptom 2], and [symptom 3]
On the basis [symptom 1], [symptom 2], and [symptom 3], [disease name] must be differentiated from disseminated intravascular coagulation (DIC) , thrombotic thrombocytopenic purpura (TTP),systemic vasculitis , [disease 4], [disease 5], and [disease 6].
Diseases | Clinical manifestations | Para-clinical findings | Gold standard | Additional findings | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms | Physical examination | ||||||||||||||||||||||||||
Lab Findings | Occur | Histopathology | |||||||||||||||||||||||||
Diarrhea | Abdominal pain | decrease urin | Physical exam 1 | Physical exam 2 | fd | CBC | PC | PT | PTT | FDP | D-dimer | LDH | haptoglobin | Coombs test | PBS | BUN | Cr | S/C | Pediatric | Adult | Imaging 3 | ||||||
Disseminated intravascular coagulation (DIC) | NL/_ | ↑ | ↑ | ↑ | ↑ | ||||||||||||||||||||||
Hemolytic uremic syndrome | Hemolitic anemia | NL | NL | NL | ↑ | ↑ | ↑ | ↑ | ↑ | +++ | + | ||||||||||||||||
Thrombotic thrombocytopenic purpura (TTP) | + | +++ | |||||||||||||||||||||||||
Systemic vasculitis | |||||||||||||||||||||||||||
Diseases | Symptom 1 | Symptom 2 | Symptom 3 | Physical exam 1 | D | Physical exam 3 | Lab 1 | Lab 2 | Lab 3 | Imaging 1 | Imaging 2 | Imaging 3 | Histopathology | Gold standard | Additional findings | ||||||||||||
Differential Diagnosis 4 | |||||||||||||||||||||||||||
Differential Diagnosis 5 | |||||||||||||||||||||||||||
Differential Diagnosis 6 |
References
Pathophysiology
- The pathophysiolgy of xxx disease in unknown.
- But it may follow xxx pathway
- It is believed that xxx might work on yyy to produce zz.
Pathology
- Idiopathic
- Itarogenic
- cardiac
References
History & clinical symptoms | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Blood test | hemolysate | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Diagnosis of abnormal hemoglobins | Diagnisis of β-thalassemia | Dignisis of α-thalassemia | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Alkaline electrophoresis • acid electrophoresis •HPLC | Electrophoresis HPLC • HbA2,Hbf | Electrophoresis HPLC • DNA testing | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Evidence of abnormality,comparison of mobility with that of known abnormalities, if HBS suspected: solubility test | Separation/quantification | Evalution of all data and findings | Evalution of all data and findings | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Diagnisis of β-thalassemia | Dignisis of α-thalassemia | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
DNA sequencing if needed | DNA sequencing if needed(thalassemia major, thalassemia intermedia | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Evaluation of all data and findings(including blood count ethnic and origin | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Diagnosis of hemoglobinopathy | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||